Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 23, 2017

DrugPatentWatch Database Preview

Daptomycin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for daptomycin and what is the scope of freedom to operate?

Daptomycin
is the generic ingredient in three branded drugs marketed by Crane Pharms Llc, Teva Parenteral, Hospira Inc, and Cubist Pharms Llc, and is included in four NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Daptomycin has twenty-seven patent family members in nineteen countries.

There are nine drug master file entries for daptomycin. Four suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: daptomycin

Tradenames:3
Patents:3
Applicants:4
NDAs:4
Drug Master File Entries: see list9
Suppliers / Packagers: see list4
Bulk Api Vendors: see list49
Clinical Trials: see list18
Patent Applications: see list3,312
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:daptomycin at DailyMed

Pharmacology for Ingredient: daptomycin

Ingredient-typeLipopeptides
Drug ClassLipopeptide Antibacterial

Tentative approvals for DAPTOMYCIN

Applicant Application No. Form Dosage
► Subscribe► SubscribePOWDER;INTRAVENOUS350MG/VIAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Crane Pharms Llc
DAPTOMYCIN
daptomycin
POWDER;INTRAVENOUS206005-001Jun 15, 2016APRXNoNo► Subscribe► Subscribe
Cubist Pharms Llc
CUBICIN RF
daptomycin
POWDER;INTRAVENOUS021572-003Jul 6, 2016RXYesYes9,138,456► SubscribeY ► Subscribe
Cubist Pharms Llc
CUBICIN
daptomycin
POWDER;IV (INFUSION)021572-001Sep 12, 2003DISCNNoNo► Subscribe► Subscribe
Teva Parenteral
DAPTOMYCIN
daptomycin
POWDER;INTRAVENOUS091039-001Mar 25, 2016APRXNoNo► Subscribe► Subscribe
Cubist Pharms Llc
CUBICIN
daptomycin
POWDER;INTRAVENOUS021572-002Sep 12, 2003APRXYesYes8,003,673► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot